Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Endoscopic Tattoo Helps Fight Colon Cancer

By HospiMedica International staff writers
Posted on 29 Jan 2018
An indelible tattoo marks malignant lesions, post-polypectomy sites, and difficult-to-detect polyps to enable future identification at follow-up colonoscopy or surgery.

The Spot Ex (Camp Hill, PA, USA) Spot Ex endoscopic tattoo is designed to provide a permanent marker of malignant lesions (either proven or suspected), difficult-to-detect polyps or dysplastic areas, and polypectomy, endoscopic mucosal resection (EMR), or endoscopic submucosal dissection (ESD) sites. According to the European Society of Gastrointestinal Endoscopy (ESGE; Lyon, France), all lesions except those located in the cecum, adjacent to the ileocecal valve, or in the lower rectum, should be tattooed, in order to enable a lifetime of patient care follow-up.

Spot Ex comes in a pre-filled box containing 10 pre-assembled syringes. To mark a suspect lesion or polyp, 0.5-0.75ml of Spot Ex should be injected sub-mucosally into four quadrants distal to the lesion of interest, using a 23- or 25-gauge injection needle inserted at an oblique angle so that the beveled tip of the inserted needle remains entirely beneath the mucosa, and does not penetrate the serosa and the peritoneum.

“We're excited to aid in the fight against colon cancer and advance the science of endoscopic tattooing with a permanent and cost-effective solution for gastroenterologists and surgeons,” said Luke Johnson, CEO of GI Supply. “Our mission at GI Supply is to help more GI physicians do more advanced endoscopic procedures safely and efficiently, and Spot Ex is a great next step in meeting those needs.”

“We have seen a steady increase in young patients being diagnosed with colon cancer. Fortunately, earlier diagnosis and new endoscopic therapies we offer are working,” said gastroenterologist Antonio Serna, MD, of San Antonio Gastroenterology Associates (TX, USA). “But these patients need to come back for many years of surveillance. Spot Ex gives me a way to feel confident in my assessment of cancer remission or recurrence.”

Related Links:
Spot Ex


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Ultrasonic Cleaners
Large-Capacity Ultrasonic Cleaners
New
Cylindrical Water Scanning System
SunSCAN 3D
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.